Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial by Richard Furie, Raj Tummala, Brad Rovin, Frederic Houssiau, David Jayne, Eduardo Mysler, Teodora Trasieva, Catharina Lindholm, Jacob Knagenhjelm, Erik Schwetje, Weifeng Tang

Get full text